Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease

Trial Profile

Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Aug 2009

At a glance

  • Drugs BQ 788 (Primary) ; PMZ-2123 (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Aug 2009 Results published in Heart.
    • 21 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top